We are seeking a Postdoctoral Researcher to join the newly established research group led by Dr Abdullah Khan, under the joint supervisionmultiple myeloma clinician scientist Dr Sarah Gooding. Dr Khan’s research develops and applies human organoid models to investigate the basic processes of blood and immune cell production, and how these mechanisms are disrupted in ageing and disease.
This research is an industrial collaboration investigating synergistic mechanisms of drug action in the context of myeloma. The project will involve assessing the efficacy of different combinations of myeloma therapies on cell lines and primary patient cells grown in 3D model systems.
You will hold a PhD/DPhil in the life sciences and have completed a period of post-doctoral research. You will have experience of culturing primary patient material, and using said samples for a number of different downstream assays. Experience of omics and cytotoxicity assays are required. A broad background in molecular biology techniques is essential, with an ability to manage your own research including experience in supervising others. Excellent communication skills and a strong publication record are required. Experience in flow cytometry and 3D cell culture with an interest in translational research is desirable.
The post is available on a full-time basis and is fixed-term until 31 st March 2028, funded by GlaxoSmithKline.
Applications for this vacancy are to be made online. You will be required to upload a CV and supporting statement as part of your online application.
The closing date for this position is noon on Friday 1st May 2026.
£39,424 to £47,779 per annum (Grade 7)
#J-18808-Ljbffr